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Bisphenol A (BPA) is a high-production- 
volume industrial chemical used in the manu-
facture of polycarbonate and other plastic prod-
ucts and epoxy resin–based food can liners. It 
is present in both canned and plastic-packaged 
foods sold in the United States (Schecter et al. 
2010). Exposure is widespread, with detectable 
levels in urine samples from > 90% of the U.S. 
population (Calafat et al. 2008). A wide body of 
evidence from in vitro, animal, and epide  mio-
logical studies indicates the potential for BPA-
induced endocrine disruption in a number of 
organ systems. The uses, exposure, and health 
effects of BPA have been reviewed elsewhere 
[National Toxicology Program Center for the 
Evaluation of Risks to Human Reproduction 
(NTP-CERHR) 2008; Food and Agriculture 
Organization of the United Nations/World 
Health Organization 2010].
Phthalates are another common class 
of endocrine-disrupting chemicals (EDCs) 
produced in high volumes and widely used 
in consumer goods, including food packag-
ing (European Food Safety Authority 2005; 
Fromme et al. 2007; NTP-CERHR 2006; 
Wormuth et al. 2006). This family of EDCs 
includes higher-molecular-weight phthalates 
such as bis(2-ethylhexyl) phthalate [DEHP; a 
common polyvinyl chloride (PVC) additive], 
dibutyl phthalate (DBP), and butyl benzyl 
phthalate (BBP), and also lower-molecular-
weight phthalates such as dimethyl phthalate 
(DMP) and diethyl phthalate (DEP), which is 
commonly used as a solvent for fragrance. All 
of these are used in food packaging. The high-
er-molecular-weight phthalates DEHP, DBP, 
and BBP are identified as EDCs based on 
inhibition of testosterone synthesis and effects 
on the developing male reproductive system 
in rodents, whereas the lower-molecular- 
weight phthalates DEP and DMP did not 
induce these effects (Gray et al. 2000). Some 
epidemiological evidence shows associa-
tions between urinary excretion of phthalate 
metabolites and effects on the developing 
male reproductive system (Swan 2008), male 
hormone levels and semen quality (Hauser 
2008; Meeker et al. 2007, 2009), and neuro-
behavioral end points (Engel et al. 2009).
Exposure estimates based on food, air, 
dust, and consumer product concentrations 
and intake rates indicate that diet is likely to be 
a major source of exposure for BPA and DEHP 
(Fromme et al. 2007; Lakind and Naiman 
2010; NTP-CERHR 2006, 2008) and an 
important source of exposure to BBP and DBP 
(NTP-CERHR 2003a, 2003b; Wormuth et al. 
2006). Diet is expected to account for only a 
small fraction of exposure to DMP and DEP, 
which are predominantly from consumer 
product sources (Itoh et al. 2007; Wormuth 
et al. 2006). However, empiri  cal data to verify 
these estimates are limited.
Better information about exposure sources, 
such as the role of diet, is needed to provide 
reliable information about opportunities to 
reduce exposure. Many individuals seek guid-
ance to avoid exposures as a precaution while 
health effects remain under study. In addi-
tion, the U.S. Food and Drug Administration 
(FDA) recently announced its support for 
“reasonable steps” by the agency to reduce 
BPA exposure (FDA 2010).
The contribution of different sources 
and the effectiveness of exposure reduction 
strategies can be efficiently evaluated through 
longitudinal studies of small numbers of par-
ticipants in interventions designed to alter 
exposure. BPA and phthalates are suited to 
this design because they have short biological 
half-lives, non  invasive exposure biomarkers, 
and sources that can be modified by indi-
vidual behaviors. The value of this design has 
been demon  strated in studies that showed 
an increase in urinary BPA in students using 
polycarbonate drinking water bottles (Carwile 
et al. 2009); reductions in urinary pesticide 
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Ba c k g r o u n d: Bisphenol A (BPA) and bis(2-ethylhexyl) phthalate (DEHP) are high-production-
volume chemicals used in plastics and resins for food packaging. They have been associated with 
endocrine disruption in animals and in some human studies. Human exposure sources have been 
estimated, but the relative contribution of dietary exposure to total intake has not been studied 
empirically.
oBjectives: To evaluate the contribution of food packaging to exposure, we measured urinary BPA 
and phthalate metabolites before, during, and after a “fresh foods” dietary intervention.
Me t h o d s : We selected 20 participants in five families based on self-reported use of canned and 
packaged foods. Participants ate their usual diet, followed by 3 days of “fresh foods” that were not 
canned or packaged in plastic, and then returned to their usual diet. We collected evening urine 
samples over 8 days in January 2010 and composited them into pre  intervention, during interven-
tion, and post  intervention samples. We used mixed-effects models for repeated measures and 
Wilcoxon signed-rank tests to assess change in urinary levels across time.
re s u l t s: Urine levels of BPA and DEHP metabolites decreased significantly during the fresh foods 
intervention [e.g., BPA geometric mean (GM), 3.7 ng/mL pre  intervention vs. 1.2 ng/mL during 
intervention; mono-(2-ethyl-5-hydroxy hexyl) phthalate GM, 57 ng/mL vs. 25 ng/mL]. The inter-
vention reduced GM concentrations of BPA by 66% and DEHP metabolites by 53–56%. Maxima 
were reduced by 76% for BPA and 93–96% for DEHP metabolites.
co n c l u s i o n s: BPA and DEHP exposures were substantially reduced when participants’ diets were 
restricted to food with limited packaging.
key w o r d s : canned foods, diet, endocrine disruptor, exposure, food packaging, intervention design, 
pharmacokinetics, phthalates, plastics. Environ Health Perspect 119:914–920 (2011).  doi:10.1289/
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metabolites in children provided with an 
organic diet (Lu et al. 2006); and reduced 
urinary excretion of antibiotics and phtha-
lates after a 5-day Buddhist “temple stay” that 
involved a vegetarian diet (Ji et al. 2010).
In the present study, we assessed changes 
in urinary BPA and phthalate metabolite levels 
during and after a 3-day dietary inter  vention 
designed to minimize exposure to food pack-
aged in plastic or cans by substituting a 
“fresh-foods” diet. We meas  ured phthalate 
metabolites that we expected to have substan-
tial dietary sources and, for comparison, some 
metabolites for which diet is not expected to 
be a major source. We expected to see large 
reductions in BPA and the DEHP metabolites 
mono-2-ethylhexyl phthalate (MEHP), mono-
(2-ethyl-5-oxohexyl) phthalate (MEOHP), 
and mono-(2-ethyl-5-hydroxyhexyl) phthalate 
(MEHHP). We expected smaller reductions 
in monobutyl phthalate (MBUP; a metabolite 
of DBP and BBP) and mono  benzyl phthalate 
(MBZP; a metabolite of BBP) and little or no 
reduction in mono  ethyl phthalate (MEP; a 
metabolite of DEP) and mono  methyl phtha-
late (MMEP; a metabolite of DMP).
Materials and Methods
Participants. We selected five families to 
participate in a study to assess BPA and 
phthalate urine levels at three time periods: 
pre  intervention (while eating their typical diet); 
during intervention [on a special diet of fresh 
foods (no canned foods) prepared and pack-
aged almost exclusively without contact with 
plastic]; and post  intervention (after ending the 
special diet).
Sixty-three families in the greater San 
Francisco Bay Area of California responded 
to letters on five listservs by completing a brief 
online survey about demographic charac  teris-
tics and diet over the previous 2 days [see 
Supplemental Material, Initial Recruitment 
Survey (doi:10.1289/ehp.1003170)]. To 
identify families whose diet included sources 
of BPA and phthalates, we asked families to 
complete a survey on certain dietary practices. 
Eligible families had two adults and two toilet-
trained children 3–12 years of age, lived in 
the San Francisco Bay Area, had no signifi-
cant dietary restrictions, and indicated either 
the consumption of canned foods or exposure 
to at least two of these potential sources of 
dietary BPA and phthalates: a) drank from 
personal water bottles, b) drank from large 
poly  carbonate 2- to 5-gallon water bottles 
in office coolers, c) ate meals outside of the 
home, or d) ate meals micro  waved in plastic. 
Of 63 families that completed the survey, 20 
met the criteria for study inclusion. Three of 
these families could not participate because of 
logistical concerns (e.g., travel), and another 
three did not return calls. Based on telephone 
interviews with the remaining 14, we selected 
the 5 families who reported the most frequent 
consumption of canned foods and who seemed 
likely to be able to comply with the study pro-
tocol (e.g., we excluded potential participants 
who worked night shift, ate a low-carbohy-
drate diet). The age, family composition, and 
geographic location of the 9 non  participant 
families were similar to those of the 5 fami-
lies who were enrolled. The Vassar College 
Institutional Review Board approved the study 
protocol.
Dietary intervention. A caterer, whom 
the research team had informed about pos-
sible sources of BPA and phthalates to avoid, 
developed an initial set of menu options. After 
reviewing these options and sharing them 
with participants to learn their preferences, 
the research team selected a final menu.
All families received the same foods for 
the 3-day meal intervention in January 2010. 
Intervention-period foods were prepared 
almost exclusively from fresh and organic 
fruits, vegetables, grains, and meats [see 
Supplemental Material, Table 1 (doi:10.1289/
ehp.1003170)]. Preparation techniques 
avoided contact with plastic utensils and non-
stick-coated cookware, and foods were stored 
in glass containers with BPA-free plastic lids. 
Containers were filled to below the top so 
foods did not contact the lids. Researchers 
instructed families to store foods only in 
these containers during the intervention and 
to avoid micro  waving the lids. Participants 
received stainless steel water bottles and lunch 
containers to avoid other common sources of 
BPA and phthalates. Participants were encour-
aged to eat only the food provided during the 
intervention; they were advised that if they 
had to depart from the provided foods, they 
could use fresh foods, such as fruits, vegeta-
bles, eggs, peanut butter, and jelly from glass 
jars, and milk and orange juice from glass 
containers or low-density polyethylene plastic, 
if glass was not available. Coffee drinkers were 
advised to use a French press or ceramic drip 
rather than using a plastic coffee maker or 
buying coffee from a cafe.
Sample collection. Before sample col-
lection, all adult participants gave informed 
consent for themselves and their children. 
Families received pre  labeled 125-mL amber-
glass urine sampling containers (EP Scientific 
Products, Miami, OK, USA), a daily checklist 
of study activities, and guidelines for storing 
and heating foods during the intervention. 
The field director spoke with families daily to 
address questions and concerns and to remind 
the families of study requirements for the day. 
We recorded any reported deviations from the 
intervention diet at this time. Families also 
completed food questionnaires to charac  terize 
potential dietary sources of BPA and phtha-
lates during the pre- and post  intervention 
periods. Data collection spanned 8 consecu-
tive days. On days 1 and 2, families ate their 
normal diet; on day 2, the researchers deliv-
ered food for days 3–5 prepared by a local 
caterer; and on days 6–8, families returned to 
preparing their own food.
Each participant provided a urine sam-
ple in the evening, usually after dinner, on 
days 1 and 2 (pre  intervention), 4 and 5 
(intervention), and 7 and 8 (post  intervention) 
(Figure 1). No samples were collected on 
days 3 and 6, while participants transitioned 
onto and off of the inter  ven  tion. Families 
double-bagged urine specimen jars and stored 
them in their freezers until pickup within a 
week of the study’s conclusion. After pickup, 
urine samples were stored in a freezer over-
night and shipped over  night on blue ice to 
the laboratory for processing and analysis. 
Samples were stored frozen at –20°C [for 
BPA < 2 weeks; for phthalate ester metabo-
lite (PEM) < 8 weeks] before being thawed 
for analysis. After thawing, the laboratory 
archived aliquots of each individual urine 
sample at –20°C for possible future analysis.
Laboratory analysis. For each study phase 
(pre-, during, and post  intervention) we com-
bined the two urine samples collected from 
each individual. Both urine samples were 
thawed, and equal 40-mL volumes were com-
bined in a clean 120-mL amber-glass jar. 
Once mixed, a 2-mL sub  sample was taken for 
creati  nine measurement and 1-mL sub  samples 
were taken for the BPA and PEM analytical   
methods. Analysis was by HPLC/tandem mass 
Figure 1. Intervention study design (n = 20 individuals from five families). Each participant provided a total 
of six urine samples (arrows; two per phase). Paired samples collected from each individual during each 
phase were combined for analysis.
Preintervention
Urine samples collected in the evening and composited by study phase.
Day 12 34 5678
Postintervention InterventionRudel et al.
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spectrometry using isotope dilution quantifica-
tion. See Supplemental Material (doi:10.  1289/
ehp.1003170) for detailed extraction, analysis, 
and quantification methods.
Samples were analyzed in batches includ-
ing quality control samples: a procedural 
blank, one spiked reference sample, and a 
reference sample in duplicate using laboratory 
stock urine for inter- and intra  batch com-
parisons. Most limits of detection (LODs) 
were around 1 ng/mL; LODs for MMEP 
and MEP were somewhat higher but mostly 
< 10 ng/mL. All quality control samples were 
within specifications for each batch. The 
laboratory was blinded to the identity of the 
samples, including which ones represented 
inter  vention or non  intervention collections.
Data analysis. Urinary concentrations are 
reported as analyte mass per volume (nano-
grams per milliliter), unadjusted for creatinine. 
Adjustment for creatinine is commonly used 
to reduce the impact of varying dilution on 
urinary biomarker concentrations. However, 
we addressed the influence of urine dilution by 
including creatinine as a variable in our model, 
as recommended by Barr et al. (2005), and we 
conducted confirmatory analyses using both 
unadjusted and creatinine-adjusted concen-
trations. These approaches were selected for a 
number of reasons. Creatinine concentrations 
have been shown to vary with protein con-
tent of the diet (Kesteloot and Joossens 1993; 
Neubert and Remer 1998) and therefore might 
be altered during the dietary intervention. 
Furthermore, because creatinine is associated 
with age and sex (Barr et al. 2005), adjusting 
for it might bias associations between urine 
metabolite concentrations and age or sex.
We calculated a method reporting limit 
(MRL) as the maximum of the sample-
specific method LOD and the 90th percen-
tile of the four laboratory blanks. We used 
all reported data, including measure  ments 
below the MRL. Twelve percent of MMEP 
measurements were reported as non  detects, 
and for these we assigned the sample-specific 
MRL (U.S. Environmental Protection Agency 
2006). MRLs ranged from 0.25 ng/mL (BPA) 
to 7 ng/mL (MEP). Concentrations were not 
normally distributed but were approximately 
log-normal; therefore, we log-transformed 
concentrations for mixed-effects modeling 
and used nonparametric tests.
We used mixed-effects models for repeated 
measures, with family and participant included 
as multi  level random effects and creati  nine as a 
fixed effect, to evaluate changes in concentra-
tions over time. Specifically, we used a linear 
Table 1. Characteristics of the 20 participants.
Characteristic n (%)
Age (years)
< 6 3 (15)
6 to < 12 7 (35)
12 to < 20 0 (0)
20 to < 40 4 (20)
40 to < 60 6 (30)
≥ 60 0 (0)
Ethnicity
White 14 (70)
Hispanic 1 (5)
Asian 1 (5)
Mixed 4 (20)
Sex 
Male 9 (45)
Female 11 (55)
Urinary creatinine
Preintervention
< 118.6 mg/dLa 11 (55)
> 118.6 mg/dL 9 (45)
During intervention
< 118.6 mg/dL 11 (55)
> 118.6 mg/dL 9 (45)
Postintervention
< 118.6 mg/dL 13 (65)
> 118.6 mg/dL 7 (35)
aCreatinine data are classified as below or above the 
median (118.6 mg/dL) reported by Barr et al. (2005) for 
a 1988–1994 sample of 22,245 individuals (6–90 years 
of age).
Figure 2. Box plots showing the distribution of urinary levels of BPA and phthalate metabolites in pre  intervention (Pre), intervention, and post  intervention (Post) 
samples. Boxes represent values between the 25th and 75th percentiles; black lines inside boxes indicate medians; whiskers indicate the range of non  outlier 
data points (using Tukey’s definition of outliers); and circles represent outliers. The fresh food intervention was associated with significant reductions in urinary 
excretion of BPA (A) and metabolites of DEHP [MEHP (B), MOHP (C), and MEHHP (D)]. No significant changes were observed in the other phthalate metabolites 
analyzed, although there was a small reduction in the DBP metabolite MBUP (F); concentrations of MEP (E), MBZP (G), and MMEP (H) showed little change. 
Compared with the 2007–2008 NHANES sample of 2,604 individuals ≥ 6 years of age (CDC 2009), the pre  intervention medians and 95th percentile estimates for 
adults and children combined were higher for BPA (A), DEHP metabolites (B–D), MBUP (F), and MMEP (H), much lower for MEP (E), and similar for MBZP (G). The 
NHANES median for MMEP was < LOD of 1.1 ng/mL, and the NHANES 95th percentile for MEP was 2,140 ng/mL.
*p < 0.05, and **p < 0.005 for reductions or increases between intervention phases as determined by p‑value for slope in the mixed‑effects model. 
●
Pre
20.0
200
50
10
5
2
1
200
200
100
100
200 500
50
50
5
1
50
50
50
20
20
20
20
10
10
10
5
2
1
50
20
5
5
2
2
1
1
10
5
2
1
5.0
2.0
0.5
0.1
Intervention Post
BPA
C
o
n
c
e
n
t
r
a
t
i
o
n
 
(
n
g
/
m
L
)
C
o
n
c
e
n
t
r
a
t
i
o
n
 
(
n
g
/
m
L
)
C
o
n
c
e
n
t
r
a
t
i
o
n
 
(
n
g
/
m
L
)
C
o
n
c
e
n
t
r
a
t
i
o
n
 
(
n
g
/
m
L
)
C
o
n
c
e
n
t
r
a
t
i
o
n
 
(
n
g
/
m
L
)
C
o
n
c
e
n
t
r
a
t
i
o
n
 
(
n
g
/
m
L
)
C
o
n
c
e
n
t
r
a
t
i
o
n
 
(
n
g
/
m
L
)
C
o
n
c
e
n
t
r
a
t
i
o
n
 
(
n
g
/
m
L
)
**
**
●
●
●
● ●
Pre Intervention Post
MEHP
*
●
●
●
Pre Intervention Post
MEOHP
*
●
●
●
Pre Intervention Post
MEHHP
**
●
●
●
●
●
Pre Intervention Post
● ●
●
●
Pre Intervention Post
MBUP MEP
●
Pre Intervention Post
MBZP
●
●
Pre Intervention Post
MMEP
GM
NHANES 2007−2008 median
NHANES 2007−2008 95th percentile DEHP metabolitesDietary intervention to reduce BPA and DEHP
Environmental Health Perspectives  •  v o l u m e  119 | n u m b e r 7 | July 2011  917
spline model with one knot placed at the mid-
dle time point, during the intervention. The 
impacts of age (adult/child as a categorical vari-
able) and sex were evaluated as fixed effects. To 
corroborate our findings, we used Wilcoxon 
signed-rank tests on paired data to compare 
concentrations across two time periods (e.g., 
pre- and during inter  vention). Wilcoxon com-
parison of pre- and during intervention urine 
concentrations used both unadjusted and   
creatinine-adjusted concentrations.
We evaluated the influence of being 
in the same family on exposure. To evalu-
ate effects over the course of the study, we 
used variance estimates from the mixed-effects 
model. Specifically, we estimated the corre-
lation among participants within the same 
family [the intraclass correlation (ICC)] as the 
variance attributable to the random effect of 
being in the same family divided by total vari-
ance (family, participant, and residual). We 
also estimated the percent variance explained 
by being in the same family by finding the 
difference in residual variance between mod-
els with and without family. In addition, to 
compare inter- and intra  family variability at 
each time period, we used the non  parametric 
Kruskal-Wallis test, which evaluates the ratio 
of between- and within-group variability. 
Differences among families during the inter-
vention are of particular interest because when 
diet is held constant, exposure variation due to 
other sources—some of which may be shared 
by families living together—can be observed.
We conducted data management and 
analysis in R (version 12.11.0; R Development 
Core Team 2010). All statistical tests were 
conducted at the 0.05 significance level.
Results
Twenty participants (four members in each of 
five families) completed the dietary interven-
tion study and provided a total of six urine 
samples (two samples collected during each 
phase of the study). We later combined these 
to make one sample per phase for each par-
ticipant (Figure 1). The median age of the 
10 adults was 40.5 years, and the median age 
of the 10 children was 7 years. Characteristics 
of study participants are provided in Table 1.
We detected all but one of the analytes in 
100% of the samples; MMEP was detected 
in 88% of samples. Compared with the 
2007–2008 National Health and Nutrition 
Examination Survey (NHANES) sample of 
2,604 individuals ≥ 6 years of age [Centers for 
Disease Control and Prevention (CDC) 2009], 
pre  intervention medians and 95th percentile 
estimates for adults and children combined 
in the present study were higher for BPA and 
metabolites of DEHP (MEHP, MEHHP, 
and MEOHP) and for MBUP (a metabolite 
of DBP and BBP) and MMEP (a metabolite 
of DMP); much lower for the DEP metabo-
lite MEP; and similar for the BBP metabo-
lite MBZP (Figure 2, Table 2). Higher overall 
median values for BPA and DEHP were due to 
higher median values in adult study participants 
than in NHANES adults, whereas children’s 
levels were similar to NHANES median values 
for children. The pre  intervention creatinine 
medians were similar to those derived from the 
1988–1994 NHANES sample of 22,245 indi-
viduals (Barr et al. 2005).
Urinary geometric mean (GM) values of 
BPA and of the DEHP metabolites MEHP, 
MEHHP, and MEOHP were significantly 
lower during the intervention than before the 
intervention (Figure 2, Table 3). GMs were 
reduced 66%, 53%, 55%, and 56% for BPA, 
MEHP, MEOHP, and MEHHP, respectively. 
We observed similar findings with the paired 
Wilcoxon signed-rank tests for unadjusted and 
creatinine-adjusted concentrations for BPA and 
the three DEHP metabolites [see Supplemental 
Material, Figures 1 and 2 (doi:10.1289/
ehp.1003170)], although the decrease was not 
statistically significant for creatinine-adjusted 
MEHP and MEOHP. Reductions in the 
upper ends of the exposure distributions were 
larger than corresponding reductions in the 
GM values (Figure 2; see also Supplemental 
Material, Table 2). For example, the 90th 
percentiles of BPA and MEHP were reduced 
by 73% and 84%, respectively, and maxima 
Table 2. Pre  intervention concentrations of urinary analytes.
Adults (n = 10) NHANES 
adult mediana
Children (n = 10) NHANES child 
medianb
Study combined 
median
NHANES overall 
medianc Analyte MRL Min Median Max Min Median Max
Creatinine (mg/dL) 58 150 220 119–128.8 33 68 160 98.09 100 118.6
BPA (ng/mL) 0.25 1.0 4.9 11 2 1.2 2.6 16 2.4 3.4 2.1
MEHP (ng/mL) 1 3.3 7.4 190 2.1 2.1 3.9 15 2.2 4.5 2.2
MEOHP (ng/mL) 1 9.5 24 630 10.7 11 16 66 16.5 17 11.4
MEHHP (ng/mL) 1 22 50 1,400 19.6 15 35 150 27 42 20.7
MEP (ng/mL) 7 32 73 340 128 6.7 25 39 68.7 34 124
MBUPd (ng/mL) 1 18 30 160 26 34 46 160 40.1 39 28
MBZP (ng/mL) 1 2.9 8.0 32 9.9 3.9 12 82 24.2 8.3 11.7
MMEP (ng/mL) 5 < MRLe 8.1 34 < 1.1 5.7 15 38 1.2 13 < 1.1
Abbreviations: Max, maximum; Min, minimum. 
aData include creatinine medians for 30‑ to 39‑year‑olds and 40‑ to 49‑year‑olds from the Barr et al. (2005) analysis of 1988–1994 NHANES data (n = 3,259 and 2,542), and BPA and 
phthalate medians for ≥ 20 years of age from 2007–2008 data (CDC 2009; n = 1,814). bData include creatinine medians for 6‑ to 11‑year‑olds from Barr et al. (2005; n = 3,078) and BPA and 
phthalate medians for 6‑ to 11‑year‑olds from 2007–2008 data (CDC 2009; n = 389). cData include creatinine medians for 6‑ to 90‑year olds from Barr et al. (2005; n = 22,245) and BPA and 
phthalate medians for 6‑ to ≥ 85‑year‑olds from 2007–2008 data (CDC 2009; n = 2,604). dWe did not distinguish between mono‑n‑butyl phthalate and mono  isobutyl phthalate in the present 
study; therefore, NHANES medians presented for MBUP are the sum of these two forms. eThree samples were < MRL for MMEP, and one could not be analyzed for MMEP.
Table 3. Mixed‑effects model results for multi  level spline model.
Analyte
Intervention 
variable
Percent change in GM 
per time period (ng/mL)a 
95% CI for 
slope estimate 
BPA Pre vs. duringb  –66% (3.7 vs. 1.2) –1.6 to –0.55**
During vs. post  202% (1.2 vs. 3.8) 0.61 to 1.6**
MEHP Pre vs. during –53% (7.1 vs. 3.4) –1.2 to –0.16*
During vs. post 21% (3.4 vs. 4.1) –0.32 to 0.74
MEOHP Pre vs. during –55% (27 vs. 12) –1.2 to –0.2*
During vs. post 16% (12 vs. 14) –0.35 to 0.69
MEHHP Pre vs. during –56% (57 vs. 25) –1.3 to –0.25*
During vs. post 22% (25 vs. 31) –0.3 to 0.72
MEP Pre vs. during 23% (41 vs. 50) –0.059 to 0.7
During vs. post 7% (50 vs. 53) –0.28 to 0.47
MBUP Pre vs. during –25% (43 vs. 32) –0.44 to 0.043
During vs. post 11% (32 vs. 35) –0.12 to 0.36
MBZP Pre vs. during –12% (12 vs. 10) –0.38 to 0.36
During vs. post 13% (10 vs. 11) –0.22 to 0.51
MMEP Pre vs. during –4% (12 vs. 12) –0.28 to 0.32
During vs. post –19% (12 vs. 9.3) –0.5 to 0.091
Abbreviations: CI, confidence interval; Post, post  intervention; Pre, Pre  intervention. 
aPercent change in the GM between the two time periods, with GMs of the two time periods shown in parentheses. bEach 
change estimate represents the slope between the two time periods. *p < 0.05, and **p < 0.005. The intercept (which repre‑
sents the log concentration during the intervention) was significant for all models except BPA. Creatinine and age (adult vs. 
child) were included in all models; creatinine was significant for MEOHP, MEP, MBUP, MBZP, MMEP; age was significant 
for MEP, MBUP, MBZP, and MMEP; sex was not significant in any of the models and was not included in the final models. Rudel et al.
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were reduced by 76% and 96%. Consistent 
with the greater reduction at the tops of the 
exposure distributions, the lower GMs during 
the intervention were accompanied by smaller 
interquartile ranges (reductions of 75%, 48%, 
64%, and 68% for BPA, MEHP, MEOHP, 
and MEHHP, respectively) (see Supplemental 
Material, Table 2). Among the phthalates other 
than DEHP metabolites, we observed a non-
significant 25% reduction in MBUP and no 
clear differences for other analytes (Table 3).
After participants returned to their regular 
diets, BPA levels increased to approximately 
pre  intervention levels (p < 0.01) (Figure 2, 
Table 3). We also observed a significant 
increase in BPA in paired Wilcoxon signed-
rank tests using adjusted and unadjusted 
concentrations [see Supplemental Material, 
Figures 1 and 2 (doi:10.1289/ehp.1003170)]. 
The GMs of DEHP metabolites increased 
by 16–22% after the intervention, although 
this change was not statistically significant 
(Figure 2, Table 3). Creatinine concentra-
tions were reduced by the intervention (GMs, 
94 mg/dL vs. 76 mg/dL; paired Wilcoxon 
signed-rank test, p = 0.04).
Urinary concentrations did not differ sig-
nificantly between adults and children for 
BPA, but some differences were observed for 
phthalate metabolites. In the mixed-effects 
model, we observed significant differences in 
urinary concentrations between adults and 
children across the study period for MEP, 
MBUP, MBZP, and MMEP (p < 0.05; data 
not shown). Adults had significantly higher 
concentrations than did children for MEP 
(GMs for adults vs. children: pre  intervention, 
78 vs. 21 ng/mL; during intervention, 92 vs. 
27 ng/mL; post  intervention, 98 vs. 29 ng/mL),   
whereas children had significantly higher con-
centrations of MBUP (GMs for adults vs. 
children: pre  intervention, 34 vs. 53 ng/mL;   
during intervention, 35 vs. 29 ng/mL; post-
intervention, 32 vs. 38 ng/mL), MBZP 
(pre  intervention, 9.3 vs. 14 ng/mL; dur-
ing intervention, 11 vs. 9.3 ng/mL; post-
intervention, 8.3 vs.  16 ng/mL), and 
MMEP [pre  intervention, 11 vs. 13 ng/mL;   
during intervention, 10 vs. 13 ng/mL; 
post  intervention, 8.7 vs. 10 ng/mL) (see 
Supplemental Material, Table 2 (doi:10.1289/
ehp.1003170)]. Males and females did not 
differ significantly; therefore, sex was not 
included in the final model (data not shown). 
Effects of family membership on exposure. 
We used variance estimates from the mixed- 
effects model to estimate the correlations 
among participants within the same family 
(ICC) and the percentage of total variance 
explained by inclusion of family as a random 
effect. The estimated ICCs range from approxi-
mately zero for MEP to 0.27 for MMEP, indi-
cating substantial variation within families (data 
not shown). The only analyte with a substantial 
percent variance explained by family member-
ship was BPA (11%). In contrast, the percent 
variance explained by family member  ship was 
only 3.6% for MMEP, 2.6% for MBUP, and 
near zero for other metabolites.
Variation in urinary BPA was greater 
among families than within families during the 
intervention (Kruskal-Wallis test, p < 0.01) but 
not at any other time. Urinary concentrations 
during the intervention of individuals grouped 
by family are shown in Supplemental Material, 
Figure 3 (doi:10.1289/ehp.1003170). We 
observed significant variation in MEOHP 
and MEHHP among families after the inter-
vention (data not shown) and variation in 
MMEP among families during and after the 
intervention (Kruskal-Wallis test, p < 0.05).
Dietary sources. Based on daily contacts 
with the research staff, participant-reported 
compliance with the intervention protocol 
was high, and the few substitutions reported 
by participants were within the options speci-
fied in the instructions. Reported deviations 
from the intervention diet are presented in 
Supplemental Material, Table 3 (doi:10.1289/
ehp.1003170).
Potential exposure sources recorded during 
the 2 days before and 3 days after the inter-
vention included meals prepared outside the 
home, canned foods, canned soda, frozen din-
ners, drinking from polycarbonate water bot-
tles, and microwaving in plastic. All families 
reported using canned foods or having at least 
one meal outside the home during the pre- 
or post  intervention phases of the study. Two 
families reported micro  waving frozen meals in 
plastic. Seven of 10 adults and 5 of 10 children 
had canned soda. One participant reported 
repeated use of a polycarbonate beverage con-
tainer, and one family reported drinking from a 
multi  gallon polycarbonate drinking water con-
tainer on one occasion. The self-reported diet 
data we collected [see Supplemental Material, 
Table 4 (doi:10.1289/ehp.1003170)] were too 
limited to support statistical analysis of dietary 
predictors of high BPA and PEM levels.
Discussion
In this study, GM urinary BPA concentra-
tions fell by 66% and GM DEHP metabolite 
concentrations fell by 53–56% when partici-
pants began a “fresh foods” diet, suggesting that 
most BPA and DEHP intake came from food 
packaging or meals outside the home. Maxima 
declined 76% for BPA and 93–96% for DEHP 
metabolites, showing a dramatic reduction in 
the range of exposures while participants were 
eating fresh foods. In contrast, the DBP metab-
olite MBUP decreased non  significantly, and 
other phthalates showed little or no effect.
Participants’ reports of their food practices 
suggested that canned foods and beverages and 
restaurant meals were the most likely sources 
of exposure to BPA and DEHP in their usual 
diets, because participants reported limited use 
of polycarbonate water bottles, frozen prepared 
foods, and micro  waving in plastic. This infer-
ence is consistent with NHANES data showing 
higher BPA levels associated with consumption 
of meals prepared out of the home, sodas, and 
school lunches (canned foods were not assessed) 
(Lakind and Naiman 2010). Exposure to PVC 
film, commonly used in food storage at home 
and in restaurants, may be another important 
exposure source, because these films are known 
to contain BPA and DEHP (Lopez-Cervantes 
and Paseiro-Losada 2003; Petersen and Jensen 
2010) and were not used during the inter-
vention in the present study. Our inter  vention 
limited exposures to canned foods and plas-
tic food packaging by substituting fresh foods 
prepared from basic ingredients; however, it 
is difficult to determine exactly which of these 
changes in food sourcing and handling were 
responsible for the significant exposure reduc-
tions we observed.
Our findings are consistent with estimates 
that predict dietary intake as a major source 
of BPA and DEHP exposure (NTP-CERHR 
2006; Willhite et al. 2008; Wormuth et al. 
2006). Although DBP and BBP exposures are 
also predicted to be substantially from diet, we 
observed relatively little or no change in their 
metabolites (MBUP and MBZP). For DEP, 
diet is not expected to be a major source, and 
we saw no reduction in its metabolite MEP.
Our intervention did not eliminate all 
dietary sources of exposure. Food contami-
nation may occur during pre  market process-
ing of whole foods or from the presence of 
phthalates and BPA in the environment from 
which the food originates. One example is 
the migration of DEHP into milk from PVC 
tubing used in the milking process (Feng et al. 
2005). In addition, BPA, DBP, and DEHP 
have been detected in whole eggs sold in Asia, 
demonstrating the possibility for contamina-
tion before preparation and packaging (e.g., 
Shao et al. 2007). Thus, we are not surprised 
that exposure reductions in the present study 
were not as large as predicted from the NTP 
exposure assessments for BPA and DEHP, 
which estimated diet as the source of 99% and 
90% of exposure, respectively (NTP-CERHR 
2006, 2008). Our findings of little or no influ-
ence of the inter  vention on DBP and BBP 
could mean that these compounds enter food 
upstream of our intervention; that packag-
ing formulations have changed between the 
NTP estimates and our 2010 intervention; or 
that non  dietary sources are a larger compo-
nent of exposure than predicted. The report 
by Colacino (2010) showing that NHANES 
participants with higher vegetable intake had 
higher urinary MEP suggests the possibility 
that the non  significant increase in DEP during 
our intervention was due to higher vegetable 
intake, or our finding could be due to chance.Dietary intervention to reduce BPA and DEHP
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Implications of chemical differences in 
clearance time. Although BPA levels increased 
between the intervention and post  intervention 
samples, returning to preintervention levels, 
concentrations of DEHP metabolites increased 
only slightly. This could reflect a longer clear-
ance time for DEHP than for BPA. Estimates 
of elimination half-lives in primates or humans 
are 3–6 hr for BPA (Doerge et al. 2010; Taylor 
et al. 2011; Willhite et al. 2008) and 15–24 hr 
for DEHP (Koch et al. 2005). Thus, the 1-day 
lags between sampling periods may have been 
well suited for BPA pharmaco  kinetics but 
too short to fully capture changes in DEHP 
intake. This problem is more likely to affect 
the post  intervention “rebound” because the 
effective clearance time was shorter. The time 
lag from pre  intervention to inter  vention sam-
ples (when DEHP metabolites decreased) was 
48 hr (from dinner on day 2 to the first collec-
tion of intervention urine on day 4), whereas 
the lag from intervention to post  intervention 
was effectively about 34 hr (probably from 
breakfast or lunch on day 6 to the first collec-
tion of post  intervention urine on day 7). This 
approximately 14-hr discrepancy may explain 
the absence of noticeable rebound effects in 
the levels of DEHP metabolites. This explana-
tion is also supported by the non  significant 
increase in DEHP metabolite levels between 
intervention and post  intervention collec-
tions, and by the nonsignificant decrease in 
post  intervention levels compared with pre-
intervention. Alternatively, persistent (after the 
intervention) participant changes in behaviors 
that affect DEHP but not BPA exposure could 
potentially explain the pattern of DEHP levels 
after the intervention.
Residual shared family exposures. In gen-
eral, membership in a family did not have a 
large effect on exposure over the entire study 
period. However, during the intervention, 
when many dietary sources were controlled, 
we found significant between-family variation 
for BPA, suggesting that other key exposures 
are shared within a family. These shared expo-
sures likely occur in the home and may be 
due to direct contact with BPA-containing 
materials or exposure to BPA in house dust 
or indoor air (Rudel et al. 2003, 2010). For 
the phthalates (except MMEP), we did not 
observe significant between-family variation 
during the intervention, suggesting that indi-
vidual behaviors are relatively more important 
than the shared home environment. 
Differences between adults and chil-
dren and by sex. Mixed-effects models and 
Wilcoxon tests indicated significantly higher 
levels of the DEP metabolite MEP in adults 
than in children. Mixed-effects models also 
indicated significantly higher levels of the 
other phthalate metabolites (MBUP, MBZP, 
and MMEP) in children compared with 
adults across the study period. The difference 
between DEP and other phthalates may 
originate from differences in intake rate or 
exposure sources. We observed no significant 
differences between males and females. 
Limitations. Although effect estimates 
were statistically significant using multiple 
approaches, our sample size was small, and we 
cannot rule out the possible role of chance in 
our findings. However, an intervention study—
where individuals serve as their own controls—
avoids many sources of variation that can 
confound findings in cross-sectional studies.
Generalizability from this sample to 
the U.S. population is limited because the 
relatively small number of participants in a 
particular geographic location may not be 
representative. In addition, we intentionally 
selected participants who reported consum-
ing packaged and prepared foods expected to 
contain BPA and DEHP. If these participants 
consumed more packaged and prepared foods 
than typical Americans, our results could 
over  state the role of these sources in over-
all exposure. However, our observation that 
exposures before the interven  tion were gen-
erally in the range of those reported for the 
U.S. population by the CDC (Calafat et al. 
2008) suggests that our findings are likely to 
be broadly relevant to American diets.
Although participants reported high 
compliance with the study intervention, we 
cannot be sure that all deviations from the 
intervention diet were reported. The con-
sumption of non  approved foods during the 
intervention might have reduced the effect 
of the intervention. In addition, families may 
have responded to study information by low-
ering their intake of BPA- or phthalate-con-
taining foods at any time before or during the 
study, reducing the effect of the intervention.
Conclusions
Three days of eating food with limited food 
packaging was associated with substantial 
reductions in BPA and DEHP exposures. 
Results of this study suggest that removing 
BPA and DEHP from food packaging will 
significantly decrease exposure for adults and 
children. More generally, these results illus-
trate how intervention studies of chemicals 
in consumer products can inform regulatory 
decision making, product formulation, and 
consumer choices.
RefeRences
Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, 
Pirkle JL. 2005. Urinary creatinine concentrations in the 
U.S. population: implications for urinary biologic monitoring 
measurements. Environ Health Perspect 113:192–200.
Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL. 2008. 
Exposure of the U.S. population to bisphenol A and 4‑tertiary‑
octylphenol: 2003–2004. Environ Health Perspect 116:39–44.
Carwile JL, Luu HT, Bassett LS, Driscoll DA, Yuan C, Chang JY, 
et al. 2009. Polycarbonate bottle use and urinary bisphenol A 
concentrations. Environ Health Perspect 117:1368–1372.
CDC (Centers for Disease Control and Prevention). 2009. Fourth 
National Report on Human Exposure to Environmental 
Chemicals. Available: http://www.cdc.gov/exposurereport/
data_tables/index.html#DataTablesByChemicalGroup 
[accessed 10 March 2011].
Colacino JA, Harris TR, Schecter A. 2010. Dietary intake is asso‑
ciated with phthalate body burden in a nationally represen‑
tative sample. Environ Health Perspect 118:998–1003.
Doerge DR, Twaddle NC, Woodling KA, Fisher JW. 2010. 
Pharmacokinetics of bisphenol A in neonatal and adult 
rhesus monkeys. Toxicol Appl Pharmacol 248:1–11.
Engel SM, Zhu C, Berkowitz GS, Calafat AM, Silva MJ, 
Miodovnik A, et al. 2009. Prenatal phthalate exposure and 
performance on the Neonatal Behavioral Assessment 
Scale in a multiethnic birth cohort. Neurotoxicology 
30:522–528.
European Food Safety Authority. 2005. Opinion of the Scientific 
Panel on Food Additives, Flavourings, Processing Aids and 
Materials in Contact with Food (AFC) on a request from 
the Commission related to bis (2‑ethyl  hexyl) phthalate 
(DEHP) for use in food contact materials. EFSA J 243:1–20. 
Available: http://www.efsa.europa.eu/en/efsajournal/
doc/243.pdf [accessed 26 May 2011]. 
FDA (Food and Drug Administration). 2010. Update on Bisphenol A 
for Use in Food Contact Applications: January 2010. Available: 
http://www.fda.gov/NewsEvents/PublicHealthFocus/
ucm197739.htm [accessed 27 October 2010].
Feng YL, Zhu JP, Sensenstein R. 2005. Development of a head‑
space solid‑phase microextraction method combined with 
gas chromatography mass spectrometry for the deter‑
mination of phthalate esters in cow milk. Anal Chim Acta 
538:41–48.
Food and Agriculture Organization of the United Nations/
World Health Organization. 2010. Joint FAO/WHO Expert 
Meeting to Review Toxicological and Health Aspects of 
Bisphenol A: Summary Report. Available: http://www.who.
int/entity/foodsafety/chem/chemicals/BPA_Summary2010.
pdf [accessed 2 June 2011].
Fromme H, Gruber L, Schlummer M, Wolz G, Bohmer S, Angerer J, 
et al. 2007. Intake of phthalates and di(2‑ethylhexyl)adipate: 
results of the Integrated Exposure Assessment Survey 
based on duplicate diet samples and biomonitoring data. 
Environ Int 33:1012–1020.
Gray LE Jr, Ostby J, Furr J, Price M, Veeramachaneni DN, 
Parks L. 2000. Perinatal exposure to the phthalates DEHP, 
BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual 
differentiation of the male rat. Toxicol Sci 58:350–365.
Hauser R. 2008. Urinary phthalate metabolites and semen qual‑
ity: a review of a potential biomarker of susceptibility. Int J 
Androl 31:112–117.
Itoh H, Yoshida K, Masunaga S. 2007. Quantitative identification 
of unknown exposure pathways of phthalates based on 
measuring their metabolites in human urine. Environ Sci 
Technol 41:4542–4547.
Ji K, Lim Kho Y, Park Y, Choi K. 2010. Influence of a five‑day 
vege  tarian diet on urinary levels of antibiotics and phthalate 
metabolites: a pilot study with “temple stay” participants. 
Environ Res 110:375–382.
Kesteloot HE, Joossens JV. 1993. Relationship between dietary 
protein intake and serum urea, uric acid and creatinine, 
and 24‑hour urinary creatinine excretion: the BIRNH Study. 
J Am Coll Nutr 12:42–46.
Koch HM, Bolt HM, Preuss R, Angerer J. 2005. New metabo‑
lites of di(2‑ethylhexyl)phthalate (DEHP) in human urine 
and serum after single oral doses of deuterium‑labelled 
DEHP. Arch Toxicol 79:367–376.
Lakind JS, Naiman DQ. 2010. Daily intake of bisphenol A and 
potential sources of exposure: 2005–2006 National Health 
and Nutrition Examination Survey. J Expo Sci Environ 
Epidemiol 21:272–279; doi: 10.1038/jes.2010.9 [Online 
17 March 2010].
Lopez‑Cervantes J, Paseiro‑Losada P. 2003. Determination of 
bisphenol A in, and its migration from, PVC stretch film 
used for food packaging. Food Addit Contam 20:596–606.
Lu C, Toepel K, Irish R, Fenske RA, Barr DB, Bravo R. 2006. 
Organic diets significantly lower children’s dietary exposure 
to organophosphorus pesticides. Environ Health Perspect 
114:260–263.
Meeker JD, Calafat AM, Hauser R. 2007. Di(2‑ethylhexyl) phtha‑
late metabolites may alter thyroid hormone levels in men. 
Environ Health Perspect 115:1029–1034.
Meeker JD, Calafat AM, Hauser R. 2009. Urinary metabolites of 
di(2‑ethylhexyl) phthalate are associated with decreased 
steroid hormone levels in adult men. J Androl 30:287–297.
Neubert A, Remer T. 1998. The impact of dietary protein intake Rudel et al.
920  v o l u m e  119 | n u m b e r 7 | July 2011  •  Environmental Health Perspectives
on urinary creatinine excretion in a healthy pediatric popu‑
lation. J Pediatr 133:655–659.
NTP‑CERHR (National Toxicology Program Center for the 
Evaluation of Risks to Human Reproduction). 2003a. 
NTP‑CERHR  Monograph  on  the  Potential  Human 
Reproductive and Developmental Effects of Butyl Benzyl 
Phthalate (BBP). NIH 03‑4487. Available: http://ntp.niehs.nih.
gov/ntp/ohat/phthalates/bb‑phthalate/BBP_Monograph_
Final.pdf [accessed 26 May 2011]. 
NTP‑CERHR (National Toxicology Program Center for the 
Evaluation of Risks to Human Reproduction). 2003b. 
NTP‑CERHR  Monograph  on  the  Potential  Human 
Reproductive and Developmental Effects of Di‑n‑Butyl 
butyl Phthalate (DBP). Available: http://ntp.niehs.nih.
gov/ntp/ohat/phthalates/dbp/DBP_Monograph_Final.pdf 
[accessed 26 May 2011]. 
NTP‑CERHR (National Toxicology Program Center for 
the Evaluation of Risks to Human Reproduction). 2006. 
NTP‑CERHR  Monograph  on  the  Potential  Human 
Reproductive and Developmental Effects of Di(2‑Ethylhexyl) 
Phthalate. NIH 06‑4476. Available: http://ntp.niehs.nih.gov/
ntp/ohat/phthalates/dehp/DEHP‑Monograph.pdf [accessed 
26 May 2011]. 
NTP‑CERHR (National Toxicology Program Center for the 
Evaluation of Risks to Human Reproduction). 2008. NTP‑
CERHR Monograph on the Potential Human Reproductive 
and Developmental Effects of Bisphenol A. NIH 08‑5994. 
Available: http://ntp.niehs.nih.gov/ntp/ohat/bisphenol/
bisphenol.pdf [accessed 26 May 2011]. 
Petersen JH, Jensen LK. 2010. Phthalates and food‑contact 
materials: enforcing the 2008 European Union plastics 
legislation. Food Addit Contam Part A Chem Anal Control 
Expo Risk Assess 27:1608–1616. 
R Development Core Team. 2010. R: A Language and Environment 
for Statistical Computing. Vienna:R Foundation for Statistical 
Computing.
Rudel RA, Camann DE, Spengler JD, Korn LR, Brody JG. 2003. 
Phthalates, alkylphenols, pesticides, poly  brominated diphe‑
nyl ethers, and other endocrine‑disrupting compounds in 
indoor air and dust. Environ Sci Technol 37:4543–4553.
Rudel RA, Dodson RE, Perovich LJ, Morello‑Frosch R, Camann DE, 
Zuniga MM, et al. 2010. Semivolatile endocrine‑disrupting 
compounds in paired indoor and outdoor air in two northern 
California communities. Environ Sci Technol 44:6583–6590.
Schecter A, Malik N, Haffner D, Smith S, Harris TR, Paepke O, 
et al. 2010. Bisphenol A (BPA) in U.S. Food. Environ Sci 
Technol 44:9425–9430; doi: 10.1021/es102785d [Online 
1 November 2010]. 
Shao B, Han H, Tu X, Huang L. 2007. Analysis of alkylphenol and 
bisphenol A in eggs and milk by matrix solid phase disper‑
sion extraction and liquid chromatography with tandem 
mass spectrometry. J Chromatogr B 850:412–416.
Swan SH. 2008. Environmental phthalate exposure in relation 
to reproductive outcomes and other health endpoints in 
humans. Environ Res 108:177–184.
Taylor JA, Vom Saal FS, Welshons WV, Drury B, Rottinghaus G, 
Hunt PA, et al. 2011. Similarity of bisphenol A pharmaco‑
kinetics in rhesus monkeys and mice: relevance for human 
exposure. Environ Health Perspect 119:422–430.
U.S. Environmental Protection Agency. 2006. Data Quality 
Assessment: Statistical Methods for Practitioners. EPA 
QA/G‑9S. Available: http://www.epa.gov/QUALITY/qs‑docs/
g9s‑final.pdf [accessed 20 January 2011].
Willhite CC, Ball GL, McLellan CJ. 2008. Derivation of a bisphenol 
A oral reference dose (RfD) and drinking‑water equivalent 
concentration. J Toxicol Environ Health B Crit Rev 11:69–146.
Wormuth M, Scheringer M, Vollenweider M, Hungerbuhler K. 
2006. What are the sources of exposure to eight frequently 
used phthalic acid esters in Europeans? Risk Anal 26:803–824.